Overview

Pharmacokinetics of Aqueous Dexamethasone

Status:
Enrolling by invitation
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
The study is being done to measure the absorption of the DEXTENZA implant and inflammation concentration levels in the eye.
Phase:
Phase 4
Details
Lead Sponsor:
Frank A. Bucci, Jr., M.D.
Treatments:
Dexamethasone